ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ANGPT1 | Angiopoietin 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT2 | Angiopoietin 2 | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ARF6 | ADP-ribosylation factor 6 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BRAP | BRCA1 associated protein | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM3 | Calmodulin 3 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALML3 | Calmodulin-like 3 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CALML6 | Calmodulin-like 6 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enriched |
CDC42 | Cell division cycle 42 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CSF1 | Colony stimulating factor 1 (macrophage) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
CSF1R | Colony stimulating factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
EFNA1 | Ephrin-A1 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
EFNA3 | Ephrin-A3 | Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EFNA4 | Ephrin-A4 | Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
EFNA5 | Ephrin-A5 | Cancer-related genes Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
EGF | Epidermal growth factor | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELK1 | ELK1, member of ETS oncogene family | Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ETS2 | V-ets avian erythroblastosis virus E26 oncogene homolog 2 | Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EXOC2 | Exocyst complex component 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
FASLG | Fas ligand (TNF superfamily, member 6) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGF10 | Fibroblast growth factor 10 | Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF11 | Fibroblast growth factor 11 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF12 | Fibroblast growth factor 12 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF13 | Fibroblast growth factor 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF14 | Fibroblast growth factor 14 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF16 | Fibroblast growth factor 16 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Not detected |
FGF17 | Fibroblast growth factor 17 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF19 | Fibroblast growth factor 19 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF20 | Fibroblast growth factor 20 | Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF22 | Fibroblast growth factor 22 | Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
FGF23 | Fibroblast growth factor 23 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |